Medscape has launched a new educational activity in their “Clinical Advances in Gene Therapy for Hemophilia” series, which is presented through a collaboration between Medscape, the National Hemophilia Foundation, the European Haemophilia Consortium and the World Federation of Hemophilia. The program is supported by an independent educational grant from BioMarin.
“The Science of Gene Therapy for Hemophilia,” will examine the technology behind the emerging approaches to gene therapy in hemophilia.
Upon completion of this activity, participants will have:
- Increased knowledge regarding the
- Use of gene therapy for hemophilia
- Mechanisms of gene therapy for hemophilia that affect immunity, efficacy and safety
The Science of Gene Therapy for Hemophilia
Authors: Glenn F. Pierce, MD, PhD
CME / ABIM MOC Released: 8/3/2018
Valid for credit through: 8/3/2019
If you are already registered with Medscape follow this link to “The Science of Gene Therapy for Hemophilia.”
Access this link to visit the “Clinical Advances in Gene Therapy for Hemophilia” homepage.
If you are not already registered, go to Medscape.org where registration is straightforward and free of charge.
